Search Result "TZD pioglitazone"
Pioglitazone and Cancer: Angel or Demon?
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 27 Year: 2013 Page: 4913-4929
Author(s): Michael S. Kostapanos,Moses S. Elisaf,Dimitri P. Mikhailidis
Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone
Journal: Current Drug Safety
Volume: 5 Issue: 3 Year: 2010 Page: 234-244
Author(s): Rafael Simo, Angel Rodriguez, Elena Caveda
Implication for Thiazolidinediones (TZDs) as Novel Potential Anti- Inflammatory Drugs
Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4 Issue: 5 Year: 2005 Page: 531-541
Author(s): H. Xu, D. Finas, F. Koster, G. Griesinger, M. Friedrich, K. Diedrich, D. Hornung
Pioglitazone, Bladder Cancer, and the Presumption of Innocence
Journal: Current Drug Safety
Volume: 17 Issue: 4 Year: 2022 Page: 294-318
Author(s): Georgios S. Papaetis
Simultaneous Determination of Antidiabetic Thiazolidinediones Using Flow Through Voltammetric Sensor
Journal: Current Pharmaceutical Analysis
Volume: 10 Issue: 4 Year: 2014 Page: 239-245
Author(s): Lai-Hao Wang,Yan-Lin Song
Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors
Journal: Current Clinical Pharmacology
Volume: 3 Issue: 2 Year: 2008 Page: 77-84
Author(s): Giuseppe Derosa, Sibilla A.T. Salvadeo
Pioglitazone Therapy Decreases Bone Mass Density and Increases Fat Mass: A Meta-Analysis
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 33 Year: 2019 Page: 3590-3596
Author(s): Liyun Zuo,Jianbin Wang,Nianping Zhang,Junjie Wang
Simultaneous Determination of Alogliptin and Pioglitazone in Human Plasma by a Novel LC-MS/MS Method
Journal: Current Pharmaceutical Analysis
Volume: 16 Issue: 5 Year: 2020 Page: 564-577
Author(s): Duddukuru Sri Sesha Sai Praveen,Syed Asha,Ravi Kumar Pigili
Stimulation of Peroxisome Proliferator-Activated Receptor-Gamma (PPARγ) using Pioglitazone Decreases the Survival of Acute Promyelocytic Leukemia Cells through Up-Regulation of PTEN Expression
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 1 Year: 2021 Page: 108-119
Author(s): Shadi Esmaeili,Ava Safaroghli-Azar,Atieh Pourbagheri-Sigaroodi,Sina Salari,Ahmad Gharehbaghian,Mohsen Hamidpour,Davood Bashash
PPARγ Agonists: Beneficial Effect on Blood Pressure Beyond Glycemic Control?
Journal: Current Hypertension Reviews
Volume: 2 Issue: 1 Year: 2006 Page: 47-60
Author(s): Panteleimon A. Sarafidis, Anastasios N. Lasaridis